Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Munro

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Health Technology Assessment (Winchester, England)|December 8, 2025
Optimal provision of opiate substitution therapy and needle and syringe programmes: a multi-method realist evaluationPeter McCulloch, April Shaw, Gail Gilchrist, et al.
Harm Reduction Journal|March 22, 2017
The acceptability and feasibility of a brief psychosocial intervention to reduce blood-borne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usualGail Gilchrist, Davina Swan, April Shaw, et al.
The International Journal on Drug Policy|August 2, 2021
The uptake of foil from needle and syringe provision services and its role in smoking or snorting heroin among people who inject drugs in ScotlandKaren Dunleavy, Sharon J Hutchinson, Norah Palmateer, et al.
Health Technology Assessment (Winchester, England)|December 7, 2017
Preventing blood-borne virus infection in people who inject drugs in the UK: systematic review, stakeholder interviews, psychosocial intervention development and feasibility randomised controlled trialGail Gilchrist, Davina Swan, April Shaw, et al.
The International Journal on Drug Policy|December 28, 2017
Spore forming bacteria infections and people who inject drugs: Implications for harm reductionKaren Dunleavy, Alison Munro, Kirsty Roy, et al.
Addiction (Abingdon, England)|July 16, 2017
Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugsNorah E Palmateer, David J Goldberg, Alison Munro, et al.
The International Journal on Drug Policy|February 21, 2026
Optimal provision of opioid agonist therapy (OAT) and needle and syringe programmes (NSP): a realist evaluationPeter McCulloch, Hannah Family, April Shaw, et al.
The Lancet. HIV|April 15, 2019
Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysisAndrew McAuley, Norah E Palmateer, David J Goldberg, et al.
Addiction (Abingdon, England)|March 4, 2017
Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in ScotlandJack Stone, Natasha K Martin, Matthew Hickman, et al.
Archives of Women'S Mental Health|January 18, 2018
Correction to: Psychiatric comorbidity and intimate partner violence among women who inject drugs in Europe: a cross-sectional studyJudit Tirado-Muñoz, Gail Gilchrist, Gabriele Fischer, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Health Technology Assessment (Winchester, England)|December 8, 2025
Optimal provision of opiate substitution therapy and needle and syringe programmes: a multi-method realist evaluationPeter McCulloch, April Shaw, Gail Gilchrist, et al.
Harm Reduction Journal|March 22, 2017
The acceptability and feasibility of a brief psychosocial intervention to reduce blood-borne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usualGail Gilchrist, Davina Swan, April Shaw, et al.
The International Journal on Drug Policy|August 2, 2021
The uptake of foil from needle and syringe provision services and its role in smoking or snorting heroin among people who inject drugs in ScotlandKaren Dunleavy, Sharon J Hutchinson, Norah Palmateer, et al.
Health Technology Assessment (Winchester, England)|December 7, 2017
Preventing blood-borne virus infection in people who inject drugs in the UK: systematic review, stakeholder interviews, psychosocial intervention development and feasibility randomised controlled trialGail Gilchrist, Davina Swan, April Shaw, et al.
The International Journal on Drug Policy|December 28, 2017
Spore forming bacteria infections and people who inject drugs: Implications for harm reductionKaren Dunleavy, Alison Munro, Kirsty Roy, et al.
Addiction (Abingdon, England)|July 16, 2017
Association between universal hepatitis B prison vaccination, vaccine uptake and hepatitis B infection among people who inject drugsNorah E Palmateer, David J Goldberg, Alison Munro, et al.
The International Journal on Drug Policy|February 21, 2026
Optimal provision of opioid agonist therapy (OAT) and needle and syringe programmes (NSP): a realist evaluationPeter McCulloch, Hannah Family, April Shaw, et al.
The Lancet. HIV|April 15, 2019
Re-emergence of HIV related to injecting drug use despite a comprehensive harm reduction environment: a cross-sectional analysisAndrew McAuley, Norah E Palmateer, David J Goldberg, et al.
Addiction (Abingdon, England)|March 4, 2017
Modelling the impact of incarceration and prison-based hepatitis C virus (HCV) treatment on HCV transmission among people who inject drugs in ScotlandJack Stone, Natasha K Martin, Matthew Hickman, et al.
Archives of Women'S Mental Health|January 18, 2018
Correction to: Psychiatric comorbidity and intimate partner violence among women who inject drugs in Europe: a cross-sectional studyJudit Tirado-Muñoz, Gail Gilchrist, Gabriele Fischer, et al.
Pageof 4